Physician profile
Natalie Sofia Weger
NPI 1205090339
$13,924.32
in general payments reported to CMS, 2019-2025
8 companies · $4,954 in 2025
The $4,954 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $131 · 2022: $651 · 2023: $2,325 · 2024: $5,659 · 2025: $4,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,749 · Food and Beverage: $3,021 · Education: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,749.09 |
| Food and Beverage | $3,021.25 |
| Education | $1,167.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,818.53 | 2022-2025 | Hawkone, Ellipsys Vascular Access System, In.Pact Admiral |
| Penumbra, INC. | $2,294.14 | 2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $1,909.17 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Propaten Vascular Graft, Gore Viabahn Endoprosthesis With Heparin |
| Bard Peripheral Vascular, INC. | $544.39 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $165.89 | 2023 | |
| Getinge USA Sales, LLC | $98.52 | 2021 | |
| Endologix LLC | $61.35 | 2022 | |
| Bolton Medical INC | $32.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Weger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.